DigestRedComo funciona
Red
/
Empresas
Ac
No verificado

Actio Biosciences

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

17 Comunicados de prensa

Ver todos los comunicados de prensa
05/12/2025
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
Industria
Actio Biosciences Announces Preclinical Data Highlighting Ability of ABS-1230 to Potently and Selectively Inhibit KCNT1 and Significantly Reduce Seizure Activity
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
24/11/2025
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Eventos
Industria
Actio Biosciences to Present New Preclinical Data for ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy, at the American Epilepsy Society Annual Meeting
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
23/09/2025
Industria
Salud
Biotecnología
Sanidad
Medicina - Varios
Farmacéutica
Actio Biosciences Announces First Participant Dosed in Phase 1 Clinical Trial of ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
10/09/2025
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Sanidad
Eventos
Actio Biosciences to Participate in TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
30/07/2025
Biotecnología
Farmacéutica
Sanidad
Salud
Higiene alimentaria
Medicina - Varios
Industria
Actio Biosciences Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
07/07/2025
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Eventos
Ferias y Congresos
Actio Biosciences to Participate in Evercore Emerging Private Biotech Conference
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
18/06/2025
Biotecnología
Higiene alimentaria
Salud
Finanzas
Sanidad
Farmacéutica
Asociaciones/Profesionales
Gestión empresarial
Material médico sanitario
Medicina - Varios
Industria
Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven Pipeline of Small Molecule Therapeutics for Rare and Common Diseases
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
09/04/2025
Ferias y Congresos
Ciencia
Biotecnología
Medicina - Varios
Sanidad
Salud
Farmacéutica
Actio Biosciences to Participate in Piper Sandler Spring Biopharma Symposium
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
03/03/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Industria
Actio Biosciences Announces First Participant Dosed in Phase 1 Clinical Trial of ABS-0871, a Novel TRPV4 Inhibitor, for the Treatment of Charcot Marie Tooth Disease 2C
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0
25/02/2025
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Industria
Actio Biosciences to Participate in Upcoming Investor Conferences
Fuente
Actio Biosciences
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0